Anticholesterol rosuvastatin not associated with reduced risk for fractures

1 diciembre 2014

Treatment with the anticholesterol medicine rosuvastatin calcium did not reduce the risk of fracture among men and women who had elevated levels of an inflammatory biomarker, according to a report. «Our study does not support the use of statins in doses used for cardiovascular disease prevention to reduce the risk of fracture,» the study concludes.